Literature DB >> 22894932

Androgen receptor serine 81 mediates Pin1 interaction and activity.

Raffaele La Montagna1, Isabella Caligiuri, Pasquale Maranta, Chiara Lucchetti, Luca Esposito, Marco G Paggi, Giuseppe Toffoli, Flavio Rizzolio, Antonio Giordano.   

Abstract

Hormone-dependent tumors are characterized by deregulated activity of specific steroid receptors, allowing aberrant expression of many genes involved in cancer initiation, progression and metastasis. In prostate cancer, the androgen receptor (AR) protein has pivotal functions, and over the years it has been the target of different drugs. AR is a nuclear receptor whose activity is regulated by a phosphorylation mechanism controlled by hormone and growth factors. Following phosphorylation, AR interacts with many cofactors that closely control its function. Among such cofactors, Pin1 is a peptidyl-prolyl isomerase that is involved in the control of protein phosphorylation and has a prognostic value in prostate cancer. In the present study, we demonstrate that ARSer81 is involved in the interaction with Pin1, and that this interaction is important for the transcriptional activity of AR. Since Pin1 expression positively correlates with tumor grade, our results suggest that Pin1 can participate in this process by modulating AR function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22894932      PMCID: PMC3466552          DOI: 10.4161/cc.21730

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

Review 1.  Molecular genetics of prostate cancer.

Authors:  C Abate-Shen; M M Shen
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 2.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli.

Authors:  Michael Frezza; Huanjie Yang; Q Ping Dou
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Post-translational modification of the androgen receptor.

Authors:  Daniel Gioeli; Bryce M Paschal
Journal:  Mol Cell Endocrinol       Date:  2011-07-24       Impact factor: 4.102

6.  Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.

Authors:  Akihide Ryo; Hiroji Uemura; Hitoshi Ishiguro; Tatsuya Saitoh; Akira Yamaguchi; Kilian Perrem; Yoshinobu Kubota; Kun Ping Lu; Ichiro Aoki
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

7.  Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.

Authors:  Shao-Yong Chen; Gerburg Wulf; Xiao Zhen Zhou; Mark A Rubin; Kun Ping Lu; Steven P Balk
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

8.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

9.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

10.  Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer.

Authors:  Natalia V Narizhneva; Natalia D Tararova; Petro Ryabokon; Inna Shyshynova; Anatoly Prokvolit; Pavel G Komarov; Andrei A Purmal; Andrei V Gudkov; Katerina V Gurova
Journal:  Cell Cycle       Date:  2009-12-13       Impact factor: 4.534

View more
  13 in total

1.  Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.

Authors:  Joshua W Russo; Xiaming Liu; Huihui Ye; Carla Calagua; Sen Chen; Olga Voznesensky; James Condulis; Fen Ma; Mary-Ellen Taplin; David J Einstein; Steven P Balk; Shaoyong Chen
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

Review 2.  Phosphorylation: a fundamental regulator of steroid receptor action.

Authors:  Lindsey S Treviño; Nancy L Weigel
Journal:  Trends Endocrinol Metab       Date:  2013-07-06       Impact factor: 12.015

3.  Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.

Authors:  Prashant Rajbhandari; Mary Szatkowski Ozers; Natalia M Solodin; Christopher L Warren; Elaine T Alarid
Journal:  J Biol Chem       Date:  2015-04-12       Impact factor: 5.157

Review 4.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

5.  Proline-Directed Androgen Receptor Phosphorylation.

Authors:  Yanfei Gao; Shaoyong Chen
Journal:  J Mol Genet Med       Date:  2013-10

6.  Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.

Authors:  Ryuhei Kanaoka; Akifumi Kushiyama; Yasuyuki Seno; Yusuke Nakatsu; Yasuka Matsunaga; Toshiaki Fukushima; Yoshihiro Tsuchiya; Hideyuki Sakoda; Midori Fujishiro; Takeshi Yamamotoya; Hideaki Kamata; Akio Matsubara; Tomoichiro Asano
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

7.  Pin1 promotes GR transactivation by enhancing recruitment to target genes.

Authors:  Toryn M Poolman; Stuart N Farrow; Laura Matthews; Andrew S Loudon; David W Ray
Journal:  Nucleic Acids Res       Date:  2013-07-25       Impact factor: 16.971

8.  The prolyl isomerase pin1 regulates mRNA levels of genes with short half-lives by targeting specific RNA binding proteins.

Authors:  Nithya Krishnan; Mark A Titus; Roopa Thapar
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

9.  Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.

Authors:  Nooshin Mirkheshti; Sulgi Park; Shoulei Jiang; Jodie Cropper; Sherry L Werner; Chung S Song; Bandana Chatterjee
Journal:  Oncotarget       Date:  2016-09-20

Review 10.  Posttranslational modification of the androgen receptor in prostate cancer.

Authors:  Travis van der Steen; Donald J Tindall; Haojie Huang
Journal:  Int J Mol Sci       Date:  2013-07-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.